3.59 USD
▲+0.14+4.04%
盘后 3.34 0.00%
2026-09-16
市值
$45.47M
市盈率
—
EPS
-5.22
股息率
—
52 周区间
2.49 – 20.31
成交量
164.62K
Beta
2.82
目标价
—
52W 低 2.4952W 高 20.31
价格走势
公司简介
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixe...